Skip to main content
Fig. 4 | BMC Clinical Pathology

Fig. 4

From: BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score

Fig. 4

Concordance of IHC-based methods with RS. Concordance rates were computed on 158 cases using cross-validation for each of the following methods tested (starting with the left-most bar): Magee Score #3 with the coefficients and variables described in Klein, et al. [24]; Magee Score #3 with coefficients recomputed based on our cohort; IHC Score using ER, PR, and Ki-67% positive staining, and Her2 score; IHC Score using the logistic transformation applied to ER, PR, and Ki-67; IHC Score after inclusion of BCL-2 H-score; IHC Score using both the logistic transformation and the inclusion of BCL-2 H-score

Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us